▶ 調査レポート

世界のヒトマイクロバイオーム市場2021年ー2028年:疾患別(胃腸・代謝障害、女性健康、癌、その他)、技術別、治療別

• 英文タイトル:Human Microbiome Market (Indication: Gastrointestinal & Metabolic Disorders, Women’s Health, Cancer, and Others; Technology: 16s rRNA Sequencing and Metagenomic Sequencing; and Therapeutic Area: Gastrointestinal Disorders, Metabolic Disorders, Women’s Health, Skin Disorders, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Transparency Market Researchが調査・発行した産業分析レポートです。世界のヒトマイクロバイオーム市場2021年ー2028年:疾患別(胃腸・代謝障害、女性健康、癌、その他)、技術別、治療別 / Human Microbiome Market (Indication: Gastrointestinal & Metabolic Disorders, Women’s Health, Cancer, and Others; Technology: 16s rRNA Sequencing and Metagenomic Sequencing; and Therapeutic Area: Gastrointestinal Disorders, Metabolic Disorders, Women’s Health, Skin Disorders, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028 / MRC2204A105資料のイメージです。• レポートコード:MRC2204A105
• 出版社/出版日:Transparency Market Research / 2022年1月
• レポート形態:英文、PDF、176ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥857,660 (USD5,795)▷ お問い合わせ
  Multi User¥1,301,660 (USD8,795)▷ お問い合わせ
  Corporate License¥1,745,660 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Transparency Market Research社の本調査レポートは、世界のヒトマイクロバイオーム市場について調査し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、疾患別(胃腸・代謝障害、女性健康、癌、その他)分析、治療別分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などを掲載しています。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・キーインサイト
・世界のヒトマイクロバイオーム市場規模:疾患別(胃腸・代謝障害、女性健康、癌、その他)
・世界のヒトマイクロバイオーム市場規模:治療別
・世界のヒトマイクロバイオーム市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)
・競争状況

Human Microbiome Market – Scope of Report
TMR’s report on the global human microbiome market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global human microbiome market for the period 2017–2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global human microbiome market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global human microbiome market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global human microbiome market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global human microbiome market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global human microbiome market.

The report delves into the competition landscape of the global human microbiome market. Key players operating in the global human microbiome market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global human microbiome market that have been profiled in this report.

Key Questions Answered in Human Microbiome Market Report
What is the scope of growth of human microbiome diagnostics & therapeutics in the global human microbiome market?
What will be the Y-o-Y growth of the global human microbiome market between 2021 and 2028?
What is the influence of changing trends in technologies on the global human microbiome market?
Which region will continue to be the most profitable market for human microbiome?
Which factors are anticipated to hamper the growth of the global human microbiome market during the forecast period?
Which are the leading companies in the global human microbiome market?
Research Methodology
A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global human microbiome market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global human microbiome market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the human microbiome market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the human microbiome market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global human microbiome market with accuracy. The study also uses the top-down approach to assess the revenue for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global human microbiome market more reliably and accurately.

レポート目次

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Human Microbiome Market
4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Human Microbiome Market Analysis and Forecast, 2017–2028
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. COVID-19 Impact on the Human Microbiome Market
5.2. Microbiome Therapeutics Pipeline Scenario
5.3. Regulatory Scenario across globe
5.4. Impact of human microbiome therapeutics on current treatment options
5.5. Key Mergers & Acquisitions
6. Global Human Microbiome Market Analysis and Forecast, by Indication
6.1. Introduction & Definition
6.1.1. Key Findings / Developments
6.2. Global Human Microbiome Market Value Forecast, by Indication, 2017–2028
6.2.1. Gastrointestinal & Metabolic Disorders
6.2.2. Women’s Health
6.2.3. Cancer
6.2.4. Others
6.3. Global Human Microbiome Market Attractiveness Analysis, by Indication
6.4. Global Human Microbiome Market Analysis and Forecast, by Technology
6.4.1. Introduction & Definition
6.4.2. Key Findings / Developments
6.5. Global Human Microbiome Market Value Forecast, by Technology, 2017–2028
6.5.1. 16s rRNA Sequencing
6.5.2. Metagenomic Sequencing
6.6. Global Human Microbiome Market Attractiveness Analysis, by Technology
7. Global Human Microbiome Market Analysis and Forecast, by Therapeutic Area
7.1. Introduction & Definition
7.1.1. Key Findings / Developments
7.2. Global Human Microbiome Market Value Forecast, by Therapeutic Area, 2017–2028
7.2.1. Gastrointestinal Disorders
7.2.2. Metabolic Disorders
7.2.3. Women’s Health Disorders
7.2.4. Skin Disorders
7.2.5. Others
7.3. Global Human Microbiome Market Attractiveness Analysis, by Therapeutic Area
8. Global Human Microbiome Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Global Human Microbiome Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. North America Human Microbiome Market Attractiveness Analysis, by Region
9. North America Human Microbiome Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. North America Human Microbiome Market Value (US$ Mn) Forecast, by Indication, 2017–2028
9.2.1. Gastrointestinal & Metabolic Disorders
9.2.2. Women’s Health
9.2.3. Cancer
9.2.4. Others
9.3. North America Human Microbiome Market Value (US$ Mn) Forecast, by Technology, 2017–2028
9.3.1. 16s rRNA Sequencing
9.3.2. Metagenomic Sequencing
9.4. North America Human Microbiome Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017–2028
9.4.1. Gastrointestinal Disorders
9.4.2. Metabolic Disorders
9.4.3. Women’s Health Disorders
9.4.4. Skin Disorders
9.4.5. Others
9.5. North America Human Microbiome Market Value (US$ Mn) Forecast, by Country, 2017–2028
9.5.1. U.S.
9.5.2. Canada
9.6. North America Human Microbiome Market Attractiveness Analysis
9.6.1. By Indication
9.6.2. By Technology
9.6.3. By Therapeutic Area
9.6.4. By Country
10. Europe Human Microbiome Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Europe Human Microbiome Market Value (US$ Mn) Forecast, by Indication, 2017–2028
10.2.1. Gastrointestinal & Metabolic Disorders
10.2.2. Women’s Health
10.2.3. Cancer
10.2.4. Others
10.3. Europe Human Microbiome Market Value (US$ Mn) Forecast, by Technology, 2017–2028
10.3.1. 16s rRNA Sequencing
10.3.2. Metagenomic Sequencing
10.4. Europe Human Microbiome Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017–2028
10.4.1. Gastrointestinal Disorders
10.4.2. Metabolic Disorders
10.4.3. Women’s Health Disorders
10.4.4. Skin Disorders
10.4.5. Others
10.5. Europe Human Microbiome Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Italy
10.5.5. Spain
10.5.6. Rest of Europe
10.6. Europe Human Microbiome Market Attractiveness Analysis
10.6.1. By Indication
10.6.2. By Technology
10.6.3. By Therapeutic Area
10.6.4. By Country/Sub-region
11. Asia Pacific Human Microbiome Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Asia Pacific Human Microbiome Market Value (US$ Mn) Forecast, by Indication, 2017–2028
11.2.1. Gastrointestinal & Metabolic Disorders
11.2.2. Women’s Health
11.2.3. Cancer
11.2.4. Others
11.3. Asia Pacific Human Microbiome Market Value (US$ Mn) Forecast, by Technology, 2017–2028
11.3.1. 16s rRNA Sequencing
11.3.2. Metagenomic Sequencing
11.4. Asia Pacific Human Microbiome Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017–2028
11.4.1. Gastrointestinal Disorders
11.4.2. Metabolic Disorders
11.4.3. Women’s Health Disorders
11.4.4. Skin Disorders
11.4.5. Others
11.5. Asia Pacific Human Microbiome Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Asia Pacific Human Microbiome Market Attractiveness Analysis
11.6.1. By Indication
11.6.2. By Technology
11.6.3. By Therapeutic Area
11.6.4. By Country/Sub-region
12. Latin America Human Microbiome Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Latin America Human Microbiome Market Value (US$ Mn) Forecast, by Indication, 2017–2028
12.2.1. Gastrointestinal & Metabolic Disorders
12.2.2. Women’s Health
12.2.3. Cancer
12.2.4. Others
12.3. Latin America Human Microbiome Market Value (US$ Mn) Forecast, by Technology, 2017–2028
12.3.1. 16s rRNA Sequencing
12.3.2. Metagenomic Sequencing
12.4. Latin America Human Microbiome Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017–2028
12.4.1. Gastrointestinal Disorders
12.4.2. Metabolic Disorders
12.4.3. Women’s Health Disorders
12.4.4. Skin Disorders
12.4.5. Others
12.5. Latin America Human Microbiome Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Latin America Human Microbiome Market Attractiveness Analysis
12.6.1. By Indication
12.6.2. By Technology
12.6.3. By Therapeutic Area
12.6.4. By Country/Sub-region
13. Middle East & Africa Human Microbiome Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Middle East & Africa Human Microbiome Market Value (US$ Mn) Forecast, by Indication, 2017–2028
13.2.1. Gastrointestinal & Metabolic Disorders
13.2.2. Women’s Health
13.2.3. Cancer
13.2.4. Others
13.3. Middle East & Africa Human Microbiome Market Value (US$ Mn) Forecast, by Technology, 2017–2028
13.3.1. 16s rRNA Sequencing
13.3.2. Metagenomic Sequencing
13.4. Middle East & Africa Human Microbiome Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017–2028
13.4.1. Gastrointestinal Disorders
13.4.2. Metabolic Disorders
13.4.3. Women’s Health Disorders
13.4.4. Skin Disorders
13.4.5. Others
13.5. Middle East & Africa Human Microbiome Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Latin America Human Microbiome Market Attractiveness Analysis
13.6.1. By Indication
13.6.2. By Technology
13.6.3. By Therapeutic Area
13.6.4. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (by tier and size of companies)
14.2. Market Share / Position Analysis, by Company, 2020
14.3. Company Profiles
14.3.1. AOBiome
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. Strategic Overview
14.3.1.4. SWOT Analysis
14.3.2. Enterome Biosciences SA
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. Strategic Overview
14.3.2.4. SWOT Analysis
14.3.3. Metabiomics Corp. (BioSpherex LLC)
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. Strategic Overview
14.3.3.4. SWOT Analysis
14.3.4. Microbiome Therapeutics LLC
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. Strategic Overview
14.3.4.4. SWOT Analysis
14.3.5. Osel, Inc.
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. Strategic Overview
14.3.5.4. SWOT Analysis
14.3.6. Second Genome
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. Strategic Overview
14.3.6.4. SWOT Analysis
14.3.7. Seres Therapeutics
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. Financial Overview
14.3.7.4. Strategic Overview
14.3.7.5. SWOT Analysis
14.3.8. Synthetic Biologics, Inc.
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. Financial Overview
14.3.8.4. Strategic Overview
14.3.8.5. SWOT Analysis
14.3.9. Vedanta Biosciences
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Product Portfolio
14.3.9.3. Financial Overview
14.3.9.4. Strategic Overview
14.3.9.5. SWOT Analysis
14.3.10. 4D Pharma
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Product Portfolio
14.3.10.3. Financial Overview
14.3.10.4. Strategic Overview
14.3.10.5. SWOT Analysis
14.3.11. Ferring Pharmaceuticals
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Product Portfolio
14.3.11.3. Financial Overview
14.3.11.4. Strategic Overview
14.3.11.5. SWOT Analysis

List of Table

Table 1: Key Mergers and Acquisitions

Table 2: Global Human Microbiome Diagnostic Market Size (US$ Mn) Forecast, by Indication, 2017–2028

Table 3: Global Human Microbiome Diagnostic Market Size (US$ Mn) Forecast, by Technology, 2017–2028

Table 4: Global Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Therapeutic Area, 2020–2028

Table 5: Global Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, by Region, 2017-2028

Table 6: Global Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Region, 2020-2028

Table 7: North America Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, by Indication, 2017–2028

Table 8: North America Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017–2028

Table 9: North America Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, by Country, 2017–2028

Table 10: North America Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Therapeutic Area, 2020–2026

Table 11: North America Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Country, 2020–2028

Table 12: Europe Human Microbiome Diagnostic Market Size (US$ Mn) Forecast, by Indication, 2017–2028

Table 13: Europe Human Microbiome Diagnostic Market Size (US$ Mn) Forecast, by Technology, 2017–2028

Table 14: Europe Human Microbiome Diagnostic Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

Table 15: Europe Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Therapeutic Area, 2020–2028

Table 16: Europe Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Country, 2020–2028

Table 17: Asia Pacific Human Microbiome Diagnostic Market Size (US$ Mn) Forecast, by Indication, 2017–2028

Table 18: Asia Pacific Human Microbiome Diagnostic Market Size (US$ Mn) Forecast, by Technology, 2017–2028

Table 19: Asia Pacific Human Microbiome Diagnostic Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

Table 20: Asia Pacific Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Therapeutic Area, 2020–2028

Table 21: Asia Pacific Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020–2028

Table 22: Latin America Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, by Indication, 2017–2028

Table 23: Latin America Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017–2028

Table 24: Latin America Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

Table 25: Latin America Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Therapeutic Area, 2020–2028

Table 26: Latin America Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020–2028

Table 27: Middle East & Africa Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, by Indication, 2017–2028

Table 28: Middle East & Africa Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017–2028

Table 29: Middle East & Africa Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

Table 30: Middle East & Africa Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Therapeutic Area, 2020–2028

Table 31: Middle East & Africa Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020–2028